 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
|
|
|
|
Phase IV
|
|
|
|
GERCOR-TAUROX
SANOFI-GERCOR-TAUROX, EU-20573, NCT00274885
|
|
| |
Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction
|
|
|
|
Phase IV
|
|
|
|
ELLA
NCT00280709
|
|
| |
Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
FRE-FNCLCC-ACCORD-11/0402
EU-20512, NCT00112658
|
|
| |
Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
SGI-RUB-048
NCT00113256
|
|
| |
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
FRX106365
NCT00312013
|
|
| |
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
|
|
|
|
Phase III, Phase II
|
|
|
|
AMT/P2CA/001
LC003AURON2005, NCT00332280
|
|
| |
Efficacy Study of Endoscopic Ultrasonography (EUS)-Guided Ethanol Lavage With Paclitaxel Injection for Cystic Tumors of the Pancreas
|
|
|
|
Phase III, Phase II
|
|
|
|
AMC0183
NCT00689715
|
|
| |
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
|
|
|
|
Phase III
|
|
|
|
FCCC-FCRB-04-003-P
FCRB-04-003-P, NCT00365508
|
|
| |
A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer
|
|
|
|
Phase III
|
|
|
|
GV-001.004
NCT00051467
|
|
| |
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
|
|
|
|
Phase III
|
|
|
|
CRUK-TELOVAC-V4
EUDRACT-2006-000461-10, EU-20683, ISRTCN43482138, NCT00425360, TELOVAC
|
|
